Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rune Midgard

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Multiple Sclerosis and Related Disorders|February 26, 2021
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosisKristin Wesnes, Kjell-Morten Myhr, Trond Riise, et al.
Neurology|June 16, 2012
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatmentKristin I Løken-Amsrud, Trygve Holmøy, Søren J Bakke, et al.
Plos One|September 27, 2013
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activityTrygve Holmøy, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, et al.
Journal of Neuroimmunology|March 17, 2015
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin I Løken-Amsrud, et al.
Journal of Neuroimmunology|November 5, 2015
Body mass index influence interferon-beta treatment response in multiple sclerosisSilje Stokke Kvistad, Kjell-Morten Myhr, Trygve Holmøy, et al.
Journal of Neuroimmunology|April 10, 2014
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin Ingeleiv Løken-Amsrud, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2022
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple SclerosisIngrid Anne Lie, Kristin Wesnes, Silje S Kvistad, et al.
Plos One|May 17, 2012
Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian populationAngelina H Maniaol, Ahmed Elsais, Åslaug R Lorentzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2022
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal studyIngrid Anne Lie, Sezgi Kaçar, Kristin Wesnes, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Multiple Sclerosis and Related Disorders|February 26, 2021
Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosisKristin Wesnes, Kjell-Morten Myhr, Trond Riise, et al.
Neurology|June 16, 2012
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatmentKristin I Løken-Amsrud, Trygve Holmøy, Søren J Bakke, et al.
Plos One|September 27, 2013
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activityTrygve Holmøy, Kristin Ingeleiv Løken-Amsrud, Søren Jacob Bakke, et al.
Journal of Neuroimmunology|March 17, 2015
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin I Løken-Amsrud, et al.
Journal of Neuroimmunology|November 5, 2015
Body mass index influence interferon-beta treatment response in multiple sclerosisSilje Stokke Kvistad, Kjell-Morten Myhr, Trygve Holmøy, et al.
Journal of Neuroimmunology|April 10, 2014
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosisEgil Røsjø, Kjell-Morten Myhr, Kristin Ingeleiv Løken-Amsrud, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2022
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple SclerosisIngrid Anne Lie, Kristin Wesnes, Silje S Kvistad, et al.
Plos One|May 17, 2012
Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian populationAngelina H Maniaol, Ahmed Elsais, Åslaug R Lorentzen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2022
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal studyIngrid Anne Lie, Sezgi Kaçar, Kristin Wesnes, et al.
Pageof 4